CytomX Therapeutics, Inc.
CTMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001501989
No open-market purchases or sales by CytomX Therapeutics, Inc. insiders were filed in the last 90 days; 178 institutions reported holding it in 13F filings for Q2 2026, worth $799.0M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding CytomX Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 126 | 1 | 122 | −3 |
| Shares | 54.6M | 17.1K | 56.7M | +2.09M (+3.8%) |
| Value | $422.2M | $132.0K | $358.9M | −$63.1M (−15.0%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held CytomX Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| OrbiMed Advisors LLC | 1,513,168 | $9.58M | 0.10% |
| Great Point Partners LLC | 1,000,000 | $6.33M | 1.42% |
| QS Investors, LLC | 50,800 | $322.0K | 0.00% |
| Susquehanna Fundamental Investments, LLC | 39,463 | $250.0K | 0.00% |
| Public Employees Retirement System of Ohio | 34,609 | $219.0K | 0.00% |
| ExodusPoint Capital Management, LP | 26,224 | $166.0K | 0.00% |
| XTX Topco Ltd | 21,422 | $136.0K | 0.05% |
| Qube Research & Technologies Ltd | 18,101 | $115.0K | 0.00% |
| IPG Investment Advisors LLC | 12,500 | $79.1K | 0.02% |
| Amalgamated Bank | 11,782 | $75.0K | 0.00% |
| Balyasny Asset Management LLC | 10,059 | $64.0K | 0.00% |
| Simplex Trading, LLC | 6,168 | $39.0K | 0.00% |
| Advisory Services Network, LLC | 412 | $3.00K | 0.00% |
| Advisor Group Holdings, Inc. | 46 | $0 | 0.00% |
Sold out (17)
Institutions that held CytomX Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| BVF Inc | 5,576,471 | $43.1M |
| Janus Henderson Group PLC | 312,667 | $2.42M |
| Connor, Clark & Lunn Investment Management Ltd. | 92,243 | $713.0K |
| California Public Employees Retirement System | 91,500 | $707.0K |
| TD Asset Management Inc | 78,821 | $609.0K |
| DuPont Capital Management Corp | 66,285 | $512.0K |
| State of Wisconsin Investment Board | 61,800 | $478.0K |
| Man Group plc | 45,988 | $355.0K |
| Quilter Plc | 30,000 | $232.0K |
| Dynamic Technology Lab Private Ltd | 20,978 | $162.0K |
| Congress Park Capital LLC | 20,207 | $156.0K |
| Gsa Capital Partners LLP | 19,093 | $148.0K |
| Walleye Capital LLC | 17,345 | $134.0K |
| Martingale Asset Management L P | 16,827 | $131.0K |
| Trexquant Investment LP | 13,810 | $107.0K |
| DekaBank Deutsche Girozentrale | 10,100 | $74.0K |
| Pacer Advisors, Inc. | 3,806 | $29.0K |
Not filed for Q2 2021 yet (1)
Institutions that held CytomX Therapeutics, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| WestHill Financial Advisors, Inc. | 17,082 | $132.0K |